Kazuchika Nishitsuji

Dr. Kazuchika Nishitsuji

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SMShiho Minakata
Shiho Minakata
SMShino Manabe
Shino Manabe
YIYoko Inai
Yoko Inai
MIMidori Ikezaki
Midori Ikezaki
KNKazuchika Nishitsuji
Kazuchika Nishitsuji
YIYoshito Ihara
Yoshito Ihara
C-Mannosylation is a post-translational modification of proteins in the endoplasmic reticulum. Monomeric α-mannose is attached to specific Trp residues at the first Trp in the Trp-x-x-Trp/Cys (W-x-x-W/C) motif of substrate proteins, by the action of C-mannosyltransferases, DPY19-related gene products. The acceptor substrate proteins are included in the thrombospondin type I repeat (TSR) superfamily, cytokine receptor type I family, and others. Previous studies demonstrated that C-mannosylation plays critical roles in the folding, sorting, and/or secretion of substrate proteins. A C-mannosylation-defective gene mutation was identified in humans as the disease-associated variant affecting a C-mannosylation motif of W-x-x-W of ADAMTSL1, which suggests the involvement of defects in protein C-mannosylation in human diseases such as developmental glaucoma, myopia, and/or retinal defects. On the other hand, monomeric C-mannosyl Trp (C-Man-Trp), a deduced degradation product of C-mannosylated proteins, occurs in cells and extracellular fluids. Several studies showed that the level of C-Man-Trp is upregulated in blood of patients with renal dysfunction, suggesting that the metabolism of C-Man-Trp may be involved in human kidney diseases. Together, protein C-mannosylation is considered to play important roles in the biosynthesis and functions of substrate proteins, and the altered regulation of protein C-manosylation may be involved in the pathophysiology of human diseases. In this review, we consider the biochemical and biomedical knowledge of protein C-mannosylation and C-Man-Trp, and introduce recent studies concerning their significance in biology and medicine.

14 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NINaoyuki Iwahashi
Naoyuki Iwahashi
MIMidori Ikezaki
Midori Ikezaki
TNTaro Nishikawa
Taro Nishikawa
NNNorihiro Namba
Norihiro Namba
TOTakashi Ohgita
Takashi Ohgita
KNKazuchika Nishitsuji
Kazuchika Nishitsuji
Significance: Approximately 50 human diseases are associated with deposition of abnormally aggregated proteins that propagate in a prion-like manner. The tumor suppressor p53 forms amyloid-like aggregates; however, how p53 aggregates propagate remains unclear. Here, we identified heparan sulfate (HS), the common and major nonprotein component of in vivo deposits of various protein aggregates, as a mediator of prion-like propagation of p53 aggregates in cultured cells. Our immunohistochemical analysis showing codeposition of p53 and highly sulfated domains of HS in ovarian cancer tissues strongly support the role of HS-mediated propagation of p53 aggregates in cancer pathology. Accordingly, our results provide a mechanism of propagation of p53 aggregates that is mediated by HS. Elucidation of detailed biological relevance in cancer is warranted.

7 August 2015 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
TOTakuji Ohmoto
Takuji Ohmoto
KNKazuchika Nishitsuji
Kazuchika Nishitsuji
NYNobuyuki Yoshitani
Nobuyuki Yoshitani
MMMakoto Mizuguchi
Makoto Mizuguchi
YYYuto Yanagisawa
Yuto Yanagisawa
NSNaomi Sakashita
Naomi Sakashita
Glioblastoma is the most aggressive type of brain tumor and has a poor prognosis. Increased levels of cholesteryl ester and simultaneous expression of acyl‑CoA:cholesterol acyltransferase 1 (ACAT1) in tumor cells indicated that cholesterol esterification is critical to tumor growth. The present study confirmed that human glioblastoma tissues as well as the glioblastoma cell line U251‑MG showed significant expression of ACAT1. ACAT1 expression in U251‑MG cells increased in a cell proliferation‑dependent manner. K604, a selective ACAT1 inhibitor, suppressed the proliferation of U251‑MG cells and downregulated the activation of Akt and extracellular signal‑regulated kinase in proliferating glioblastoma cells. These results suggested that ACAT1 may be a therapeutic target for the treatment of glioblastoma, with K604 as an effective therapeutic agent.

1 July 2015 in Brain Research
Verified
Journal Article
Closed access
THTakashi Hosono
Takashi Hosono
KNKazuchika Nishitsuji
Kazuchika Nishitsuji
TNToshiyuki Nakamura
Toshiyuki Nakamura
CJCha-Gyun Jung
Cha-Gyun Jung
MKMasanori Kontani
Masanori Kontani
MMMakoto Michikawa
Makoto Michikawa

1 July 2022 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
NINaoyuki Iwahashi
Naoyuki Iwahashi
MIMidori Ikezaki
Midori Ikezaki
YKYoshihiro Komohara
Yoshihiro Komohara
YFYukio Fujiwara
Yukio Fujiwara
TNTomoko Noguchi
Tomoko Noguchi
KNKazuchika Nishitsuji
Kazuchika Nishitsuji
Recent studies suggested that aggregates of mutant p53 proteins may propagate and impair normal p53 functioning in recipient cells. Our previous study showed that cancer cell-derived p53 aggregates that cells internalized interfered with p53-dependent apoptosis in recipient cells. However, involvement of p53 aggregate propagation in cancer pathology has not been fully elucidated. Here, we screened patients with high-grade serous ovarian carcinoma, which is characterized by an extremely high frequency of TP53 gene mutations, to show that patients with cytoplasmic p53 deposits have a poor prognosis compared with patients with complete p53 absence or strong nuclear p53 positivity. Cytoplasmic p53 in the patients with poor prognosis consisted of protein aggregates, which suggests that p53 aggregates are oncogenic drivers. Indeed, an inhibitor of p53 aggregation restored cellular apoptosis, a proper p53 function, in p53 aggregate-bearing patient-derived tumor organoids. In cell-based assays, endogenous and exogenous mutant p53 aggregates hindered chemotherapeutic activity of cisplatin, which depends on normal p53 functions. This inhibition was reduced by blocking p53 aggregation or internalization of p53 aggregates. Our study, thus indicates the involvement of p53 aggregate transmission in poor prognosis and in chemotherapy resistance in cancers.

19 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
NINaoyuki Iwahashi
Naoyuki Iwahashi
MIMidori Ikezaki
Midori Ikezaki
MFMasakazu Fujimoto
Masakazu Fujimoto
YKYoshihiro Komohara
Yoshihiro Komohara
YFYukio Fujiwara
Yukio Fujiwara
KNKazuchika Nishitsuji
Kazuchika Nishitsuji
High-grade serous ovarian carcinoma (HGSOC) is an epithelial cancer that accounts for most ovarian cancer deaths. Metabolic abnormalities such as extensive aerobic glycolysis and aberrant lipid metabolism are well-known characteristics of cancer cells. Indeed, accumulation of lipid droplets (LDs) in certain types of malignant tumors has been known for more than 50 years. Here, we investigated the correlation between LD accumulation and clinical prognosis. In 96 HGSOC patients, we found that high expression of the LD marker adipophilin was associated with poor progression-free and overall survival (p = 0.0022 and p = 0.014, respectively). OVCAR-3 ovarian carcinoma cells accumulated LDs in a glucose-dependent manner, which suggested the involvement of aerobic glycolysis and subsequently enhanced lipogenesis, with a result being LD accumulation. The acyl-CoA: cholesterol acyltransferase 1 inhibitor K604 and the hydroxymethylglutaryl-CoA reductase inhibitor pitavastatin blocked LD accumulation in OVCAR-3 cells and reduced phosphorylation of the survival-related kinases Akt and ERK1/2, both of which have been implicated in malignancy. Our cell-based assays thus suggested that enhanced aerobic glycolysis resulted in LD accumulation and activation of survival-related kinases. Overall, our results support the idea that cancers with lipogenic phenotypes are associated with poor clinical prognosis, and we suggest that adipophilin may serve as an independent indicator of a poor prognosis in HGSOC.